دورية أكاديمية
أعرض في EDS

Cardiogenic shock in autoimmune rheumatologic diseases: an insight on etiologies, management, and treatment outcomes.

التفاصيل البيبلوغرافية
العنوان: Cardiogenic shock in autoimmune rheumatologic diseases: an insight on etiologies, management, and treatment outcomes.
المؤلفون: Battisha A; University of Massachusetts Medical School - Baystate, Springfield, MA, USA., Sawalha K; University of Massachusetts Medical School - Baystate, Springfield, MA, USA., Altibi AM; Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.; Henry Ford Health System (HFHS), Jackson, MI, USA., Madoukh B; Overland Park Regional Medical Center - HCA Midwest Health, Kansas City, MO, USA., Al-Akchar M; Southern Illinois University School of Medicine, Springfield, IL, USA., Patel B; Heart and Vascular Institute, West Virginian University, 1 Medical Center Dr., Morgantown, WV, 26505, USA. Brijesh.patel@wvumedicine.org.
المصدر: Heart failure reviews [Heart Fail Rev] 2022 Jan; Vol. 27 (1), pp. 93-101.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Kluwer Academic Publishers Country of Publication: United States NLM ID: 9612481 Publication Model: Print Cited Medium: Internet ISSN: 1573-7322 (Electronic) Linking ISSN: 13824147 NLM ISO Abbreviation: Heart Fail Rev Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Norwell, MA : Kluwer Academic Publishers, c1996-
مواضيع طبية MeSH: Arthritis, Rheumatoid* , Autoimmune Diseases*/complications , Rheumatic Diseases*/complications, Adult ; Female ; Humans ; Middle Aged ; Shock, Cardiogenic/epidemiology ; Shock, Cardiogenic/etiology ; Shock, Cardiogenic/therapy ; Treatment Outcome
مستخلص: Autoimmune rheumatological disorders are known to have an increased risk for cardiovascular diseases including coronary artery disease (CAD), myocarditis, pericarditis, valvulopathy, and in consequence cardiogenic shock. Data on cardiogenic shock in rheumatological diseases are scarce; however, several reports have highlighted this specific entity. We sought to review the available literature and highlight major outcomes and the management approaches in each disease. Systematic literature search, including PubMed, Ovid/Medline, Cochrane Library, and Web of Science, was conducted between January 2000 and December 2009. We reviewed all cases reporting cardiogenic shock with rheumatologic conditions, including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), Takayasu's arteritis (TA), granulomatosis with polyangiitis (GPA), giant cell arteritis (GCA), and antiphospholipid syndrome (APS). We selected 45 papers reporting a total of 48 cases. Mean age was 39 ± 7.3 years and 68.8% were females. Most common rheumatologic conditions associated with cardiogenic shock were SLE (31%), GPA (23%), TA (14.6%), APA (10.4%), and RA (8.3%). Cardiogenic shock was found to be caused by eosinophilic myocarditis in 58% of cases, CAD in 19% of cases, and valvulopathy in 6% of cases. Most patient required high-dose steroids and second immunosuppressant therapy. Mechanical circulatory supported was required in 23 cases, IABP in 16 cases, and ECMO in 12 cases. Complete recovery occurred in 37 patients while 9 patients died and 2 required heart transplant. Responsible for two-thirds of cases, eosinophilic myocarditis should be suspected in young cardiogenic shock patients with underlying rheumatologic conditions. Lupus and GPA are the two most common conditions.
(© 2020. Springer Science+Business Media, LLC, part of Springer Nature.)
References: Van Der Laan-Baalbergen NE, Mollema SA, Kritikos H et al (2009) Heart failure as presenting manifestation of cardiac involvement in systemic lupus erythematosus. Neth J Med 67(9):2957–301.
Baquero G, Banchs JE, Naccarelli GV, Gonzalez M, Wolbrette DL (2012) Cardiogenic shock as the initial presentation of systemic lupus erythematosus: a case report and review of the literature. Congest Heart Fail 18:337–341. https://doi.org/10.1111/j.1751-7133.2011.00283.x. (PMID: 10.1111/j.1751-7133.2011.00283.x22507209)
Barnado A, Kamen DL (2014) Myocarditis successfully treated with intravenous immunoglobulin in a patient with systemic lupus erythematous and myositis. Am J Med Sci 347:256–257. https://doi.org/10.1097/MAJ.0000000000000232. (PMID: 10.1097/MAJ.000000000000023224521767)
Moher D, Liberati A, Tetzlaff J, Altman DG, Group TP (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097. https://doi.org/10.1371/journal.pmed.1000097. (PMID: 10.1371/journal.pmed.10000971962107219621072)
Shaefi S, O’Gara B, Kociol RD et al (2015) Effect of cardiogenic shock hospital volume on mortality in patients with cardiogenic shock. J Am Heart Assoc 4:e001462. https://doi.org/10.1161/JAHA.114.001462. (PMID: 10.1161/JAHA.114.001462255590144330069)
Shah M, Patel B, Tripathi B, Agarwal M, Patnaik S, Ram P, Patil S, Shin J, Jorde UP (2018) Hospital mortality and thirty day readmission among patients with non-acute myocardial infarction related cardiogenic shock. Int J Cardiol 270:60–67. https://doi.org/10.1016/j.ijcard.2018.06.036. (PMID: 10.1016/j.ijcard.2018.06.03629929933)
Sheikh H, Siddiqui M, Uddin SMM, Haq A, Yaqoob U (2018) The clinicopathological profile of eosinophilic myocarditis. Cureus. https://doi.org/10.7759/cureus.3677.
Al Ali AM, Straatman LP, Allard MF, Ignaszewski AP (2006) Eosinophilic myocarditis: case series and review of literature. Can J Cardiol 22:1233–1237. https://doi.org/10.1016/S0828-282X(06)70965-5. (PMID: 10.1016/S0828-282X(06)70965-5171517742569073)
Brambatti M, Matassini MV, Adler ED, Klingel K, Camici PG, Ammirati E (2017) Eosinophilic myocarditis: characteristics, treatment, and outcomes. J Am Coll Cardiol 70:2363–2375. https://doi.org/10.1016/j.jacc.2017.09.023. (PMID: 10.1016/j.jacc.2017.09.02329096807)
Song T, Jones DM, Homsi Y (2017) Therapeutic effect of anti-IL-5 on eosinophilic myocarditis with large pericardial effusion. BMJ Case Rep. https://doi.org/10.1136/bcr-2016-218992.
Tariq S, Garg A, Gass A, Aronow WS (2018) Myocarditis due to systemic lupus erythematosus associated with cardiogenic shock. Arch Med Sci 14:460–462. https://doi.org/10.5114/aoms.2017.68692. (PMID: 10.5114/aoms.2017.6869229593821)
Malhotra G, Chua S, Kodumuri V, Sivaraman S, Ramdass P (2016) Rare presentation of lupus myocarditis with acute heart failure-a case report. Am J Ther 23:e1952–e1955. https://doi.org/10.1097/MJT.0000000000000295. (PMID: 10.1097/MJT.000000000000029526580581)
Bouiller K, Naudion P, Humbert S, Gil H, Meaux-Ruault N, Cravat M, Revel L, Molimard C, Seronde MF, Magy-Bertrand N (2018) Cardiac shock revealing systemic lupus erythematosus. Circ Heart Fail 11:e005159. https://doi.org/10.1161/CIRCHEARTFAILURE.118.005159. (PMID: 10.1161/CIRCHEARTFAILURE.118.00515929980596)
Leung MCH, Harper RW, Boxall J (2002) Extracorporeal membrane oxygenation in fulminant myocarditis complicating systemic lupus erythematosus. Med J Aust 176:374–375. https://doi.org/10.5694/j.1326-5377.2002.tb04458.x. (PMID: 10.5694/j.1326-5377.2002.tb04458.x12041632)
Apirami M, Pratheepan JA, Kumanan T, Guruparan M, Selvaratnam G (2018) Cardiogenic shock: an unusual initial presentation of Churg-Strauss syndrome. Case Rep Rheumatol 2018:1–3. https://doi.org/10.1155/2018/2076837. (PMID: 10.1155/2018/2076837)
Bitar AY, Thompson CD, Tan CW, Allem K, Khachatrian A, Weis PJ, Garg V, Srivastava A (2016) Coronary artery vasospasm and cardiogenic shock as the initial presentation for eosinophilic granulomatosis with polyangiitis. J Cardiol Cases 13:105–108. https://doi.org/10.1016/j.jccase.2015.12.001. (PMID: 10.1016/j.jccase.2015.12.00130546619)
Zardkoohi O, Hobbs R, Tan CD (2011) A rare shock. Am J Med 124:1019–1022. https://doi.org/10.1016/j.amjmed.2011.06.008. (PMID: 10.1016/j.amjmed.2011.06.00821944162)
Bouabdallaoui N, Arlet JB, Hagege AA (2015) Cardiogenic shock, asthma, and hypereosinophilia. Am J Emerg Med 33:309.e1–309.e2. https://doi.org/10.1016/j.ajem.2014.08.019. (PMID: 10.1016/j.ajem.2014.08.019)
Allaoui A (2017) Acute coronary syndrome in a young lady: a rare presentation of Takayasu disease. MOJ Clin Med Case Rep 6(3):557–57.
Tacoy G, Akyel A, Tavil Y, Cengel A (2010) Patient with Takayasu arteritis presented as cardiogenic shock. Futur Cardiol 6:889–893. https://doi.org/10.2217/fca.10.93. (PMID: 10.2217/fca.10.93)
Ishiyama Y, Eguchi K, Yokota K, Ikemoto T, Kario K (2018) New-onset Takayasu’s arteritis as acute myocardial infarction. Intern Med 57:1415–1420. https://doi.org/10.2169/internalmedicine.9690-17. (PMID: 10.2169/internalmedicine.9690-17293214305995707)
Isaza N, Posada AM, Diaz ME, Isaza-Restrepo D (2018) Cardiogenic shock as the first manifestation of large vessel vasculitis in a young patient: case report. Eur Heart J Case Rep 2(3). https://doi.org/10.1093/ehjcr/yty091.
Jedidi M, Chkirbene Y, Abdessayed N, Masmoudi T, Mahjoub M, Mlayeh S, Dhiab MB, Souguir MK, Yacoubi MT (2017) Sudden death due to unusual complication of Takayasu arteritis: an autopsy case. Am J Forensic Med Pathol 38:91–93. https://doi.org/10.1097/PAF.0000000000000293. (PMID: 10.1097/PAF.000000000000029328106684)
Schultz M, Wimberly K, Guglin M (2019) Systemic lupus and catastrophic antiphospholipid syndrome manifesting as cardiogenic shock. Lupus 28:1350–1353. https://doi.org/10.1177/0961203319871099. (PMID: 10.1177/096120331987109931451079)
Rosenbaum AN, Anavekar NS, Ernste FC, Mankad SV, le RJ, Manocha KK, Barsness GW (2015) A case of catastrophic antiphospholipid syndrome: first report with advanced cardiac imaging using MRI. Lupus 24:1338–1341. https://doi.org/10.1177/0961203315587960. (PMID: 10.1177/096120331558796026014099)
Repéssé X, Freund Y, Mathian A, Hervier B, Amoura Z, Luyt CE (2010) Successful extracorporeal membrane oxygenation for refractory cardiogenic shock due to the catastrophic antiphospholipid syndrome. Ann Intern Med 153:487. https://doi.org/10.7326/0003-4819-153-7-201010050-00027. (PMID: 10.7326/0003-4819-153-7-201010050-0002720921559)
Lin YJ, Chung SY, Di Liang C et al (2013) Impact of extracorporeal membrane oxygenation support on clinical outcome of pediatric patients with acute cardiopulmonary failure: a single-center experience. Biomed J 36:28. https://doi.org/10.4103/2319-4170.107161. (PMID: 10.4103/2319-4170.10716123515152)
Clark AL, Liu Y (2016) Biventricular stress-induced cardiomyopathy and cardiogenic shock secondary to rheumatoid arthritis flare. J Clin Exp Cardiolog 7:7.
Lin CY, Hsu CY, Huang PH (2014) Rapid resolution of severe myocardial dysfunction in a patient with rheumatoid arthritis by intravenous immunoglobulin and steroid treatment. Acta Cardiol Sin. https://doi.org/10.6515/ACS20131102A.
Pappas DA, Taube JM, Bathon JM, Giles JT(2008) A 73-year-old woman with rheumatoid arthritis and shortness of breath. In: Arthritis Care and Research. https://doi.org/10.1002/art.23720.
Booth K, Abdelrahman W, Flynn C, Jones M (2013) A giant complication at an early age: an unusual cause of cardiac tamponade. Asian Cardiovasc Thorac Ann 21:496–497. https://doi.org/10.1177/0218492312471673. (PMID: 10.1177/021849231247167324570547)
Niclauss L, Letovanec I, Chassot PG, Gersbach PA, Von Segesser LK (2008) Acute aortic valve insufficiency and cardiogenic shock due to an isolated giant cell inflammation of the aortic valve leaflets: case report and review of the literature. J Heart Valve Dis 17(3):3437–7.
Bekić D, Pekić P, Mačković M, Marić N (2015) Cardiogenic shock and complete heart block as a manifestation of fulminant Wegener’s granulomatosis. Signa Vitae 10(S1):617–62.
Raghunathan V, Pelcovits A, Gutman D, Carino G (2017) Cardiogenic shock from coronary vasculitis in granulomatosis with polyangiitis. BMJ Case Rep. https://doi.org/10.1136/bcr-2017-220233.
Bae S, Khanlou N, Charles-Schoeman C (2017) Cardiac transplantation in dermatomyositis: a case report and literature review. Hum Pathol (N Y) 8:55–58. https://doi.org/10.1016/j.ehpc.2017.03.005. (PMID: 10.1016/j.ehpc.2017.03.005)
Yukiiri K, Mizushige K, Ueda T, Nanba T, Tanimoto K, Wada Y, Takagi Y, Ohmori K, Kohno M (2001) Fulminant myocarditis in polymyositis. Jpn Circ J 65:991–993. https://doi.org/10.1253/jcj.65.991. (PMID: 10.1253/jcj.65.99111716253)
Ahlehoff O, Skov L, Gislason G, Gniadecki R, Iversen L, Bryld LE, Lasthein S, Lindhardsen J, Kristensen SL, Torp-Pedersen C, Hansen PR (2015) Cardiovascular outcomes and systemic anti-inflammatory drugs in patients with severe psoriasis: 5-year follow-up of a Danish nationwide cohort. J Eur Acad Dermatol Venereol 29:1128–1134. https://doi.org/10.1111/jdv.12768. (PMID: 10.1111/jdv.1276825303139)
Allanore Y, Avouac J, Kahan A (2008) Systemic sclerosis: an update in 2008. Joint Bone Spine 75:650–655. https://doi.org/10.1016/j.jbspin.2008.07.003. (PMID: 10.1016/j.jbspin.2008.07.00318838329)
Lambova S (2014) Cardiac manifestations in systemic sclerosis. World J Cardiol 6:993–1005. https://doi.org/10.4330/wjc.v6.i9.993. (PMID: 10.4330/wjc.v6.i9.993252763004176808)
Carreira PE (2004) Pulmonary hypertension in autoimmune rheumatic diseases. Autoimmun Rev 3:313–320. https://doi.org/10.1016/j.autrev.2003.11.004. (PMID: 10.1016/j.autrev.2003.11.00415246028)
فهرسة مساهمة: Keywords: Autoimmune disorders; Cardiogenic shock; Eosinophilic myocarditis; Granulomatosis with polyangiitis; Rheumatology; Systemic lupus erythematosus
تواريخ الأحداث: Date Created: 20200621 Date Completed: 20220124 Latest Revision: 20220124
رمز التحديث: 20231215
DOI: 10.1007/s10741-020-09990-4
PMID: 32562022
قاعدة البيانات: MEDLINE
الوصف
تدمد:1573-7322
DOI:10.1007/s10741-020-09990-4